Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol
In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire
Interactive R01 Scores Vary widely, Result Of separate Review
Fisher, Bonadonna, Croce, Hanafusa Win GAM Cancer Prizes
ASCO Honors Holland, Koop, Monaco With Special Awards
ONS To Fund 21 Grants In ’94 Deadline Dec. 1
Prevention & Control Study Section Needed: Letter to the Editor
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
